BioSpace News Archive

Bright Minds Biosciences, a biotechnology company focused on developing novel transformative treatments for neuropsychiatry disorders, epilepsy and pain, announced that Ian McDonald, Chief Executive Officer, and Dr. Gideon Shapiro Ph.D, Vice President of Discovery, will be presenting at the Benzinga Global Small Cap Conference as follows:.

Endologix LLC , a leader in the treatment of vascular disease, today announced the first implant of its ALTO® Abdominal Stent Graft in Canada following recent approval from Health Canada. ALTO was also recently approved for commercial sale in Argentina.

Adaptive Phage Therapeutics (APT), a clinical-stage biotechnology company dedicated to providing therapies to treat infectious diseases, today announced that the company has closed a $40.75 million Series B investment round led by Deerfield Management Company.

Manasi Sinha Jaiman, M.D., M.P.H., Vice President, Clinical Development at ViaCyte, Inc., a clinical-stage regenerative medicine company, will participate in the World Medical Innovation Forum’s (WMIF) Diabetes: Grand Challenge panel on Thursday, May 20, 2021

Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage biopharmaceutical company utilizing proprietary genetic engineering platform technologies to create cell and gene therapeutics with the capacity to cure, today will give multiple oral and poster presentations at the American Society of Gene and Cell Therapy 2021 Virtual Annual Meeting

CVS Pharmacy, the retail division of CVS Health, announced an upgrade to its CarePass membership program, with prescription delivery within hours now free for eligible CarePass members with an eligible prescription through an expanded partnership with the delivery service Shipt.

Apollo Medical Holdings, Inc. (“ApolloMed,” and together with its subsidiaries and affiliated entities, the “Company”) (NASDAQ: AMEH), a leading physician-centric, technology-powered healthcare management company, today announced that Brandon Sim, Chief Operating Officer and Chief Technology Officer, and Eric Chin, Chief Financial Officer, are scheduled to present at the following virtual investor events.

Rhinostics announced that it has exclusively licensed a novel nasopharyngeal swab from Innovative Product Brands, Inc. (IPB) to bring to the clinical laboratory market

Breakthrough Device Designation was awarded to Avenda Health for a male “lumpectomy” product in development designed to treat prostate cancer in-office while preserving quality of life. Breakthrough Device Designation by FDA is reserved for devices that are potentially transformative, offering treatment for serious diseases that may be more effective than currently available treatments

Candel Therapeutics, Inc., a late clinical stage biopharmaceutical company developing novel oncolytic viral immunotherapies, today announced that Carrie S. Cox has been named Chairman of the Board of Directors, effective immediately. Paul Manning, the outgoing Chairman, will continue to serve as a Director.